Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000441 · ClinicalTrials.gov registry record · Phase 4
Drug Therapy for Alcohol Detoxification
A Phase 4 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 4
- Development phase
NCT00000441 is a Phase 4 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
The verdict
NCT00000441, a Phase 4 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
This project will provide relevant clinical information for primary care practitioners treating alcohol withdrawal syndrome in outpatient settings. This double-blind, placebo- controlled clinical trial will compare the effectiveness of lorazepam (Ativan) and carbamazepine (Tegretol) in alcoholics who meet the criteria for a diagnosis of uncomplicated alcohol withdrawal syndrome. Participants are randomized to five days of treatment with a 1-week posttreatment followup.
Interventions
- DRUG lorazepam (Ativan)
- DRUG carbamazepine (Tegretol)
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2000-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000441
The ClinicalTrials.gov registry entry for NCT00000441 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lorazepam (Ativan) is the first listed.
NCT00000441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000441 about?
NCT00000441 is a clinical study titled "Drug Therapy for Alcohol Detoxification". This project will provide relevant clinical information for primary care practitioners treating alcohol withdrawal syndrome in outpatient settings. This double-blind, placebo- controlled clinical trial will compare the effectiveness of lorazepam (Ativan) and carbamazepine (Tegretol) in alcoholics wh...
What is the current status of trial NCT00000441?
This trial is currently completed. It is a Phase 4 study. Estimated completion is 2000-12.
What interventions are being tested in trial NCT00000441?
The interventions under investigation include: lorazepam (Ativan) (DRUG), carbamazepine (Tegretol) (DRUG).
Who is sponsoring clinical trial NCT00000441?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.